Nephria Bio signs exclusive agreement with Drexel University to license new “MXene” nanomaterial for future dialysis innovations

Nephria Bio signs exclusive agreement with Drexel University to license new “MXene” nanomaterial for future dialysis innovations Apr 29, 2021 On April 29, Nephria Bio, a privately held US corporation specializing in the development of innovative approaches to dialysis, announced that it signed a license agreement with Drexel University to transfer technology of new MXene […]

NephriaBio announces distribution of BIOREMA26H in Canada

NephriaBio announces distribution of BIOREMA26H in Canada Sept 16, 2023 Nephria Bio Inc. (“Nephria”) is pleased to announce its distribution of the BIOREMA26H dialysis cartridge in Canada. Developed by AllMed Medical Group GmbH, the leading global mid-market provider of dialysis products, the BioRema26H is a mid-cutoff hemodialysis cartridge which excels at lower blood flow rates, […]

NephriaBio attends Young Startup Ventures Conference

NephriaBio attends Young Startup Ventures Conference May 15, 2023 Nephria Bio attended the Young Startup Ventures Conference virtually this week, presenting on our flagship product to reimagine dialysis- Project Nephron. Project Nephron is a wearable, ambulatory hemodialysis device currently under development. Nephria Bio is raising series A financing to bring Project Nephron through development and […]